Molybdenum cofactor deficiency: Metabolic link between taurine and S-sulfocysteine

Advances in Experimental Medicine and Biology

Volumn 776, Issue , 2013, Pages 13-19

  Belaidi, Abdel Ali ^a   Schwarz, Guenter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HYPOTAURINE; S SULFOCYSTEINE; TAURINE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; MOLYBDENUM IRON PROTEIN; S SULPHOCYSTEINE; S-SULPHOCYSTEINE;

AMINO ACID ANALYSIS; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLIC DISORDER; MOLYBDENUM COFACTOR DEFICIENCY; PRIORITY JOURNAL; URINALYSIS; URINARY EXCRETION; CASE CONTROL STUDY; DISORDERS OF METAL METABOLISM; METABOLISM; URINE;

CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; HUMANS; METAL METABOLISM, INBORN ERRORS; MOLYBDOFERREDOXIN; TAURINE;

MLCS; MLOWN;

EID: 84878824641     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-6093-0_2     Document Type: Article

References (14)

1. Belaidi AA, Arjune S, Santamaria-Araujo JA, Sass JO, Schwarz G (2011) Molybdenum Cofactor Deficiency: A New HPLC Method for Fast Quantification of S-Sulfocysteine in Urine and Serum. JIMD Reports. doi:101007/8904-2011-89.
2. El Idrissi A, Trenkner E (1999) Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 19:9459-9468.
3. El Idrissi A, Trenkner E (2004) Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem Res 29:189-197.
4. Griffith OW (1987) Mammalian sulfur amino acid metabolism: an overview. Methods Enzymol 143:366-376.
5. Johnson JL, Duran M (2001) Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver C et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3163-3177.
6. Johnson JL, Waud WR, Rajagopalan KV, Duran M, Beemer FA, Wadman SK (1980) Inborn errors of molybdenum metabolism: combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor. Proc Natl Acad Sci USA 77:3715-3719.
7. Lee H-J, Adham IM, Schwarz G, Kneussel M, Sass J-O, Engel W, Reiss J (2002) Molybdenum cofactor-deficient mice resemble the phenotype of human patients. Hum Mol Gen 11:3309-3317.
8. Olney JW, Misra CH, de Gubareff T (1975) Cysteine-S-sulfate: brain damaging metabolite in sulfite oxidase deficiency. J Neuropathol Exp Neurol 34:167-177.
9. Sass JO, Nakanishi T, Sato T, Shimizu A (2004) New approaches towards laboratory diagnosis of isolated sulphite oxidase deficiency. Ann Clin Biochem 41:157-159.
10. Schwarz G, Mendel RR, Ribbe MW (2009) Molybdenum cofactors, enzymes and pathways. Nature 460:839-847.
11. Schwarz G, Santamaria-Araujo JA, Wolf S, Lee HJ, Adham IM, Grone HJ, Schwegler H, Sass JO, Otte T, Hanzelmann P, Mendel RR, Engel W, Reiss J (2004) Rescue of lethal molybdenum cofactor deficiency by a biosynthetic precursor from Escherichia coli. Hum Mol Genet 13:1249-1255.
12. Tan WH, Eichler FS, Hoda S, Lee MS, Baris H, Hanley CA, Grant PE, Krishnamoorthy KS, Shih VE (2005) Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature. Pediatrics 116:757-766.
13. Veldman A, Santamaria-Araujo JA, Sollazzo S, Pitt J, Gianello R, Yaplito-Lee J, Wong F, Ramsden CA, Reiss J, Cook I, Fairweather J, Schwarz G (2010) Successful treatment of molybdenum cofactor deficiency type A with cPMP. Pediatrics 125:e1249-e1254.
14. Zhang X, Vincent AS, Halliwell B, Wong KP (2004) A mechanism of sulfite neurotoxicity: direct inhibition of glutamate dehydrogenase. J Biol Chem 279:43035-43045.